Diabetes mellitus in ischemic stroke patients
スポンサーリンク
概要
- 論文の詳細を見る
Impaired glucose tolerance is a high-risk illness which may develop in diabetic patients, and abnormal glucose metabolism including impaired glucose tolerance is a risk factor of ischemic stroke as well as diabetes. Screening using 75-gram oral glucose tolerance test (OGTT) was useful in identifying disorders of glucose metabolism in ischemic stroke patients with no history of diabetes. A significantly large percentage of patients with ischemic stroke and no history of diabetes were found to have newly diagnosed abnormal glucose metabolism and insulin resistance by OGTT. It is the present conditions that lack scientific evidence concerning prevention for the onset and recurrence of stroke by the adjustment of blood glucose level. In ischemic stroke patients with abnormal glucose metabolism, the intervention of insulin resistance and postprandial hyperglycosemia for the purpose of suppression against the progression of atherosclerosis is a choice in the preventive cure for the recurrence of ischemic stroke. Glucagon-like peptide-1 receptor (GLP-1) agonist, exendin-4, can protect against oxidative products and neuronal cell death caused by ischemic brain damage. Exendin-4 treatment increased intracellular cAMP levels. Activation of the cAMP response could mediate GLP-1-induced brain protection in cerebral ischemia.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.